Development of a HPLC-UV method for determination of meloxicam in human plasma and pharmaceutical dosage forms
References
- 1. Shaji J, Varkey D. Development and validation of a reverse phase-hplc method for determination of meloxicam in pharmaceutical dosage forms and human plasma. Int J Pharm Sci Rev Res. 2012;12:152-160.
- 2. Kimble B, Li KM, Govendir M. Quantitation of meloxicam in the plasma of koalas (Phascolarctos cinereus) by improved high performance liquid chromatography. J Vet Sci. 2013;14:7-14.
- 3. Bandarkar FS, Vavia PR. A Stability Indicating HPLC Method for the Determination of Meloxicam in Bulk and Commercial Formulations. Tropical Journal of Pharmaceutical Research. 2009;8:257-264.
- 4. Reddy MN, Murthy TK, Rajita K, Shankar DG. New Spectrophotometric Methods For The Determination Of Meloxicam. Indian J Pharm Sci. 2001;63:245-247.
- 5. Zawilla NH, Abdul-Azim Mohammad M, El Kousy NM, El-Moghazy Aly SM. Determination of meloxicam in bulk and pharmaceutical formulations. J Pharm Biomed Anal. 2003;32:1135-1144.
- 6. Murarasu AE, Mandrescu M, Spac AF, Dorneanu V. A method for the turbidity assay of meloxicam using molybdophosphoric acid. Farmacia. 2010;58:315-321.
- 7. Altinoz S, Nemutlu E, Kir S. Polarographic behaviour of meloxicam and its determination in tablet preparations and spiked plasma. Farmaco. 2002;57:463-468.
- 8. Nemutlu E, Kir S. Method development and validation for the analysis of meloxicam in tablets by CZE. J Pharm Biomed Anal. 2003;31:393-396.
- 9. Zhang H, Choi H. Analysis of meloxicam by high-performance liquid chromatography with cloud-point extraction. Anal Bioanal Chem. 2008;392:947-953.
- 10. Rao RN, Meena S, Rao AR. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. J Pharm Biomed Anal. 2005;39:349-363.
- 11. Vignaduzzo SE, Castellano PM, Kaufman TS. Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations. J Pharm Biomed Anal. 2008;46:219-225.
- 12. Velpandian T, Jaiswal J, Bhardwaj RK, Gupta SK. Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. J Chromatogr B Biomed Sci Appl. 2000;738:431-436.
- 13. Dasandi B, Shivaprakash, Saroj H, Bhat KM. LC determination and pharmacokinetics of meloxicam. J Pharm Biomed Anal. 2002;28:999-1004.
- 14. Rigato HM, Mendes GD, Borges NC, Moreno RA. Meloxicam determination in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS-MS) in Brazilian bioequivalence studies. Int J Clin Pharmacol Ther. 2006;44:489-498.
- 15. Sinha PK, Jeswani RM, Topagi KS, Damle MC. A validated RP-HPLC method for determination of Meloxicam in the Presence of its Impurities. International Journal of PharmTech Research. 2009;1:1051-1060.
DOI: https://doi.org/10.2478/amma-2014-0031 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Language: English
Page range: 142 - 145
Submitted on: Apr 11, 2014
Accepted on: Aug 19, 2014
Published on: Nov 25, 2014
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2014 Csifo Enikő, Croitoru M. D., Fülöp Ibolya, Muntean Daniela-Lucia, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.